Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.
Credit: National Institute of Allergy and Infectious Diseases, NIH
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings.
The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research in those areas where the virus could wreak havoc on already-fragile health systems and cause the greatest health impact on vulnerable populations.
In a Comment published today in The Lancet, the members of the coalition argue that international research collaboration and coordination is needed urgently to support African, Latin American, Eastern European, and certain Asian countries to respond effectively to the worsening pandemic and speed up research adapted to resource-limited settings.
The coalition brings together an unprecedented array of health experts, including public-sector research institutes, ministries of health, academia, not-for-profit research and development organizations, NGOs, international organisations, and funders all committed to finding COVID-19 solutions for resource-poor settings.
One important research response to COVID-19 has been launched already, the World Health Organization (WHO)-led SOLIDARITY trial, an unprecedented global effort. But the authors found that out of almost 600 COVID-19 clinical trials registered, very few trials are planned in resource-poor settings. The authors commit to sharing their technical expertise and clinical trial capability to accelerate COVID-19 research in these settings.
The scale of the challenge is clearly beyond the scope of any single organization. The coalition will facilitate a coordinated approach, so that all data from all regions can be collected in a similar fashion, pooled and shared in real-time. This will help countries and the WHO to make rapid evidence-based decisions on policies and practice.
“We welcome the launch of this coalition, which takes advantage of existing multinational and multidisciplinary expertise in running clinical trials in resource poor settings, and will help the World Health Organization in its coordinating role in the global response to COVID-19,” said Dr Soumya Swaminathan, Chief Scientist, World Health Organization. “Although the epicentre is today elsewhere, we must prepare now for the consequences of this pandemic in more resource-constrained settings or we stand to lose many more lives.”
Members of the coalition call for specific commitments to ensure access, so that effective new treatments are made available as soon as possible in resource-poor settings and are affordable and readily accessible.
So far more than 70 organizations have joined this coalition, with a call made to other organizations ready to contribute existing capacity to join. Please contact the COVID-19 Clinical Research Coalition for more information: [email protected]
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 in resource-poor settings
- COVID-19: Calls for prioritized research in developing countrieson May 8, 2020 at 12:33 pm
COVID-19 has unveiled the frailty of our societies to global shocks such as disease or climate crisis. Public health experts are projecting that the center of the outbreak will shift from the United ...
- Coronavirus: Yemenis mistrust official warnings in Aden over outbreakon May 5, 2020 at 4:38 am
Sceptical that a Covid-19 outbreak has indeed emerged, residents in the port city are living life as normal - much to the horror of health officials ...
- The Challenge of Assessing Infant Vaccine Responses in Resource-poor Settingson May 3, 2020 at 5:00 pm
Newborns and infants are highly susceptible to infectious diseases, resulting in high mortality and morbidity, particularly in resource-poor settings. Many vaccines require several booster doses ...
- Statement by WHO’s Regional Office for the Eastern Mediterranean on COVID-19 in Yemenon May 2, 2020 at 12:08 pm
Collective action and commitment is the only way to mitigate the pandemic - To date, there are seven confirmed cases of COVID-19 in the south of Yemen, including two deaths, as declared by national ...
- The Challenge of Assessing Infant Vaccine Responses in Resource-poor Settingson April 29, 2020 at 5:00 pm
In addition, genetic heterogeneity between populations (for example, western versus southern settings) or ethnicity should be considered when designing studies. Other factors that may be ...
Go deeper with Google Headlines on:
COVID-19 in resource-poor settings
Go deeper with Bing News on:
Prevention and treatment of COVID-19
- Questions of bias in COVID-19 treatment add to the mourning for black familieson May 10, 2020 at 2:56 pm
For many black families, mourning coronavirus deaths brings an added burden as they wonder whether racial bias may have played a role.
- Drug treatment a stopgap for vaccine to eradicate COVID-19: Chief scientific officeron May 10, 2020 at 10:20 am
Drug treatment only a stopgap for vaccine that could eradicate the coronavirus: Johnson & Johnson's chief scientific officer said on ABC's "This Week." ...
- Diagnosis and Treatment Protocol for Covid-19 (trial version 7) Translated by Medical Universities of Chinaon May 10, 2020 at 5:53 am
JIANGXI, CHINA / ACCESSWIRE / / Medical professors' hard work finally has paid off as Jiangxi University of Traditional Chinese Medicine (JXUTCM) translated the Diagnosis and Treatment Protocol for ...
- How a llama could conquer COVID-19 and why that should inspire youon May 9, 2020 at 4:10 am
Scientists discovered that llamas have a unique antibody construction, which could lead to life-saving prevention of coronavirus in humans. How weird!
- Kansas researchers find detectable levels of COVID-19 in wastewater treatment sampleson May 8, 2020 at 12:59 pm
Researchers have found that detectable levels of COVID-19 were discovered in samples taken from 10 Kansas wastewater plants, according to preliminary findings released this week. The initial results ...